BeOne Medicines Ltd.
Close on Nov 20, 2026Market cap $44.45BP/E 69.9Yield –
BeOne Medicines Collaboration & Other Revenue by Quarter
Collaboration & Other Revenue ($M) ($M)
BeOne Medicines Collaboration & Other Revenue: $25.3M in Q2 2026, up 91.7% from a year earlier.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Operations (XBRL).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up collaboration & Other Revenue
- Collaboration & Other Revenue — United States ($M)15.6 · Q2 2026
- Collaboration & Other Revenue — China ($M)6.30 · Q2 2026
- Collaboration & Other Revenue — Europe ($M)0.30 · Q2 2026
- Collaboration & Other Revenue — Rest of World ($M)–
- Collaboration R&D Service Revenue ($M, FY16–FY22)59 · Q3 2023
- Collaboration R&D Cost Reimbursement Revenue ($M, FY16–FY21)0 · Q4 2020
- Collaboration Right-to-Access IP Revenue ($M, FY19–FY22)52 · Q3 2023
- Other Collaboration Revenue ($M, FY17–FY22)3 · Q3 2023
Cite this data
StockData. (2026). BeOne Medicines Collaboration & Other Revenue ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rev-collab-total
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.
See a number that looks wrong?